Newsroom

Welcome to the IVX Health Newsroom. Here, you can find the latest news on our company, including future market expansions, leadership updates, new formulary offerings and more.

Palm Beach, Fla., Sept. 21, 2022 /PRNewswire/ -- IVX Health today announced the opening of three new outpatient infusion centers in the greater Palm Beach area.

HARTFORD, Conn., August 30, 2022 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two infusion centers in the greater Hartford and New Haven areas, with plans to open more centers in the state of Connecticut over the coming year.

NASHVILLE, Tenn., July 19, 2022 /PRNewswire/ -- IVX Health proudly announced today it has achieved national accreditation through the Accreditation Commission for Health Care (ACHC) for the services of Ambulatory Infusion Centers.

SARASOTA, Fla., June 9, 2022 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of a new infusion center in the greater Sarasota-Bradenton area.

DAYTONA BEACH, Fla., April 7, 2022 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two new centers in the greater Daytona Beach area.

Fort Myers, Fla., Feb. 17, 2022 /Business Wire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of three new centers in the Southwest Florida region this spring.

NASHVILLE, Tenn., Feb. 8, 2022 /Business Wire/ -- –IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions, announced today the expansion of its injection formulary with the addition of Leqvio® (inclisiran), a new FDA-approved therapy by Novartis Pharmaceuticals Corporation indicated for the treatment of adult patients with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) who require additional LDL-C lowering.

NASHVILLE, Tenn., Dec. 15, 2021 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the completion of its rebrand of Precision Healthcare, following its acquisition in October 2020.

JACKSONVILLE, Fla., Oct. 19, 2021 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of three new centers in the Jacksonville metropolitan area.

NASHVILLE, Tenn. and BOSTON, Mass., Sep. 21, 2021 /Business Wire/ -- IVX Health, a national provider of outpatient infusion centers, announced today the completion of a $100 million Series F minority investment from Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies. Great Hill joins IVX Health’s existing investors including Linden Structured Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital.

Media Inquiries

Chase Pattison
Vice President, Marketing
[email protected]

Headquarters

IVX Health
214 Centerview Drive
Suite 250
Brentwood, TN 37027

Click here to find an IVX Health center near you.

Menu